These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 2886660

  • 21. Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosus.
    Buyon JP, Shadick N, Berkman R, Hopkins P, Dalton J, Weissmann G, Winchester R, Abramson SB.
    Clin Immunol Immunopathol; 1988 Jan; 46(1):141-9. PubMed ID: 2961492
    [Abstract] [Full Text] [Related]

  • 22. Immune complex injury of the lung.
    Ward PA.
    Am J Pathol; 1979 Oct; 97(1):85-92. PubMed ID: 158982
    [Abstract] [Full Text] [Related]

  • 23. Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis.
    Moxley G, Ruddy S.
    Arthritis Rheum; 1985 Oct; 28(10):1089-95. PubMed ID: 3876836
    [Abstract] [Full Text] [Related]

  • 24. Rheumatoid arthritis and systemic lupus erythematosus as immune complex diseases.
    Weissmann G.
    Bull NYU Hosp Jt Dis; 2009 Oct; 67(3):251-3. PubMed ID: 19852746
    [Abstract] [Full Text] [Related]

  • 25. Complement and dengue haemorrhagic fever/shock syndrome.
    Malasit P.
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):316-20. PubMed ID: 3501613
    [Abstract] [Full Text] [Related]

  • 26. Detection of the terminal complement complex in patient plasma following acute myocardial infarction.
    Langlois PF, Gawryl MS.
    Atherosclerosis; 1988 Mar; 70(1-2):95-105. PubMed ID: 3258520
    [Abstract] [Full Text] [Related]

  • 27. Immune-complex-mediated biologic effects.
    Wiggins RC, Cochrane CG.
    N Engl J Med; 1981 Feb 26; 304(9):518-20. PubMed ID: 6450327
    [No Abstract] [Full Text] [Related]

  • 28. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
    Perez HD, Hooper C, Volanakis J, Ueda A.
    J Immunol; 1987 Jul 15; 139(2):484-9. PubMed ID: 3648093
    [Abstract] [Full Text] [Related]

  • 29. The immunology of rheumatoid diseases.
    Koffler D.
    Clin Symp; 1979 Jul 15; 31(4):1-36. PubMed ID: 45382
    [No Abstract] [Full Text] [Related]

  • 30. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, Vanes LA.
    Clin Exp Immunol; 1983 Sep 15; 53(3):541-6. PubMed ID: 6604604
    [Abstract] [Full Text] [Related]

  • 31. Human platelet activation by C3a and C3a des-arg.
    Polley MJ, Nachman RL.
    J Exp Med; 1983 Aug 01; 158(2):603-15. PubMed ID: 6604123
    [Abstract] [Full Text] [Related]

  • 32. In vivo fixation of immune complexes on polymorphonuclear cells and release of neutrophil cationic proteins in systemic lupus erythematosus (SLE).
    Camussi G, Segoloni G, Stratta P, Berta JM, Ragni R, Piccoli G, Vercellone A.
    Proc Eur Dial Transplant Assoc; 1977 Aug 01; 14():478-85. PubMed ID: 600964
    [Abstract] [Full Text] [Related]

  • 33. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.
    Gardinali M, Padalino P, Vesconi S, Calcagno A, Ciappellano S, Conciato L, Chiara O, Agostoni A, Nespoli A.
    Arch Surg; 1992 Oct 01; 127(10):1219-24. PubMed ID: 1417490
    [Abstract] [Full Text] [Related]

  • 34. Endotoxin-induced shock in the rat. A role for C5a.
    Smedegård G, Cui LX, Hugli TE.
    Am J Pathol; 1989 Sep 01; 135(3):489-97. PubMed ID: 2789475
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis.
    Hopkins P, Belmont HM, Buyon J, Philips M, Weissmann G, Abramson SB.
    Arthritis Rheum; 1988 May 01; 31(5):632-41. PubMed ID: 3259882
    [Abstract] [Full Text] [Related]

  • 37. [Functional analysis of immune complex-rich serum fractions in autoimmune diseases by in vitro C3 activation of fresh blood].
    Böhm U, Merétey K, Falus A, Bozsóky S.
    Z Rheumatol; 1981 May 01; 40(3):126-30. PubMed ID: 6456623
    [Abstract] [Full Text] [Related]

  • 38. The biology and pathophysiology of complement receptors.
    Lambris JD, Tsokos GC.
    Anticancer Res; 1986 May 01; 6(3 Pt B):515-23. PubMed ID: 2943215
    [Abstract] [Full Text] [Related]

  • 39. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
    Marder SR, Chenoweth DE, Goldstein IM, Perez HD.
    J Immunol; 1985 May 01; 134(5):3325-31. PubMed ID: 3884709
    [Abstract] [Full Text] [Related]

  • 40. Compartmental distribution of complement activation products in artificial kidneys.
    Cheung AK, Chenoweth DE, Otsuka D, Henderson LW.
    Kidney Int; 1986 Jul 01; 30(1):74-80. PubMed ID: 3489123
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.